| MicroRNA in disease regulation | Lifetime | 86 | CN 23 | 99.51 |
| Circular RNAs in diseases | Lifetime | 46 | CN 22 | 99.45 |
| Cancer-related molecular mechanisms research | Lifetime | 162 | CN 67 | 99.28 |
| Epigenetics and DNA Methylation | Lifetime | 970 | CN 94 | 97.90 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 448 | CN 4 | 97.67 |
| Genetic Syndromes and Imprinting | Lifetime | 213 | CN 5 | 97.04 |
| Functional Brain Connectivity Studies | Lifetime | 744 | CN 39 | 98.19 |
| Genetic Associations and Epidemiology | Lifetime | 475 | CN 13 | 97.55 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 774 | CN 36 | 97.16 |
| Schizophrenia research and treatment | Lifetime | 814 | CN 14 | 97.49 |
| Bipolar Disorder and Treatment | Lifetime | 550 | CN 6 | 97.06 |
| Tryptophan and brain disorders | Lifetime | 826 | CN 25 | 96.47 |
| Congenital heart defects research | Lifetime | 925 | CN 34 | 94.10 |
| Healthcare and Venom Research | Lifetime | 809 | CN 127 | 91.71 |
| 14-3-3 protein interactions | Lifetime | 507 | CN 34 | 84.38 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 590 | CN 188 | 79.79 |
| Functional Brain Connectivity Studies | 2021-2025 | 159 | CN 32 | 98.17 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 130 | CN 6 | 95.41 |
| MicroRNA in disease regulation | 2021-2025 | 475 | CN 297 | 94.84 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 353 | CN 78 | 94.07 |
| Tryptophan and brain disorders | 2021-2025 | 343 | CN 102 | 93.51 |
| Bipolar Disorder and Treatment | 2021-2025 | 203 | CN 10 | 94.14 |
| Genetic Associations and Epidemiology | 2021-2025 | 478 | CN 48 | 91.53 |
| Mental Health Research Topics | 2021-2025 | 692 | CN 93 | 90.13 |
| Stress Responses and Cortisol | 2021-2025 | 824 | CN 98 | 83.99 |
| Schizophrenia research and treatment | 2021-2025 | 848 | CN 57 | 87.05 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | 2021-2025 | 669 | CN 37 | 84.47 |
| Treatment of Major Depression | 2021-2025 | 606 | CN 52 | 81.31 |
| Genetic Syndromes and Imprinting | 2021-2025 | 537 | CN 42 | 70.57 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 719 | CN 242 | 63.54 |
| Healthcare and Venom Research | 2021-2025 | 653 | CN 206 | 59.04 |
